(0.04%) 5 334.00 points
(0.01%) 39 946 points
(-0.02%) 18 760 points
(-1.57%) $78.55
(1.53%) $2.79
(-0.60%) $2 423.90
(-1.73%) $31.87
(-1.25%) $1 050.40
(-0.03%) $0.920
(-0.28%) $10.67
(-0.04%) $0.787
(-0.15%) $90.54
13.70% $ 18.59
Live Chart Being Loaded With Signals
LENZ Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing aceclidine-based eye drop to enhance vision in patients diagnosed with presbyopia...
Stats | |
---|---|
Dzisiejszy wolumen | 129 460 |
Średni wolumen | 286 374 |
Kapitalizacja rynkowa | 474.67M |
EPS | $0 ( 2024-05-09 ) |
Następna data zysków | ( $-0.420 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.0550 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-14 | Chevallard Daniel R. | Buy | 3 188 | Common Stock |
2024-05-13 | Mccollum James W | Buy | 31 332 | Common Stock |
2024-03-21 | Alpha Wave Ventures Gp, Ltd | Buy | 0 | Common Stock, par value $0.00001 per share |
2024-03-21 | Ra Capital Management, L.p. | Buy | 933 038 | Common Stock |
2024-03-21 | Ra Capital Management, L.p. | Buy | 2 386 301 | Common Stock |
INSIDER POWER |
---|
98.20 |
Last 38 transactions |
Buy: 7 772 479 | Sell: 70 534 |
Wolumen Korelacja
LENZ Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
LENZ Therapeutics, Inc. Korelacja - Waluta/Towar
LENZ Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.41M (0.00 %) |
EPS: | $-15.30 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.41M (0.00 %) |
EPS: | $-15.30 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing aceclidine-based eye drop to enhance vision in patients diagnosed with presbyopia. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej